nad and tirzepatide + Tirzepatide: Safety & Clinical Evidence – PlexusDx NAD+ vs Tirzepatide for Weight

A: Rebound weight gain may occur after discontinuing semaglutide treatment after prolonged use, increasing the risk for obesity-related diseases like hypertension and diabetes

Singer AJ (2010): Accidental Digital Self-Injection of Epinephrine: Debunking the Myth

F.StijnenT.CuijpersP.PenninxB

Some clinicians highlight the medications as tools that provide: Hope and reduce food-related obsession Improve mobility Increase self-efficacy Others warn that drug-driven weight loss can raise: Body image vulnerability Drive restrictive behaviors Unmask underlying mood disorders As part of care, behavioral health specialists advise screening for prior: Mental health history Monitoring new symptoms Offering psychotherapy for body image or disordered eating How Should Clinicians And Patients Monitor Mood Changes While Using Tirzepatide